Graham Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-24,839	Closed	-$2.86M	–	1368
2024 Q3	$2.86M	Buy	+24,839	New	+$2.86M	0.05%	170
2022 Q4	–	Sell	-10,529	Closed	-$1.12M	–	1220
2022 Q3	$1.12M	Buy	+10,529	New	+$1.12M	0.04%	431